Stabilization and improvement seen in multiple key biopharma r&d metrics, says iqvia institute report

Research triangle park, n.c.--(business wire)--the life sciences innovation ecosystem continued to evolve and expand in 2024 as the industry continued to adapt to a complex and dynamic range of geopolitical, technological and social uncertainties. the year saw progress in funding, trial starts, program productivity and cycle times, according to the new report, global trends in r&d 2025: progress in recapturing innovation in biopharma innovation, released by the iqvia institute for human dat.
IQV Ratings Summary
IQV Quant Ranking